Health Share Gains Big After a Strong Quarter
P3 Health Partners Shares Surge Over 42% in After‑Hours Trading
The stock jumped more than 42 % after hours, a stark contrast to the Q4 loss of $23.02 EPS, far below analyst expectations.
Revenue rose 4 % to $386 million, with per‑member revenue up 14 % thanks to new contract terms and higher rates.
Adjusted EBITDA hit $25.8 million, translating to roughly $81 per member per month.
Net profit turned positive at $3 million, reversing the $44.2 million loss recorded in the same period last year.
CEO Dr. Aric Coffman highlighted two years of focused effort on contract restructuring, network narrowing, and operational redesign as the catalyst for this turnaround.
Result: Full‑year 2026 adjusted EBITDA target raised to a midpoint of $40 million.- Guidance for the year:
- Total revenues: $1.50–$1.65 billion
Adjusted EBITDA: $20–$60 million
Market cap sits around $29 million. Over the past 12 months, the share price has fallen by more than half, trading near the lower end of its 52‑week range.
Technical indicators: Relative Strength Index ≈ 72, indicating an overbought zone.
During regular hours, P3 Health closed up nearly 13 %. Benzinga analysis points to a pattern of long‑term consolidation with short‑term gains.
